Chugai Pharmaceutical's First-Half Net Profit Rises 19% to 231.7 Billion Yen, April–June Quarter Also Up 20%

Earnings
โดย 株探ニュース·Read original
Summary · why it matters

Chugai Pharmaceutical reported consolidated net profit for the cumulative first half of the fiscal year ending December 2026 rose 19.2% year-on-year to 231.7 billion yen. For the April–June quarter, consolidated net profit increased 19.7% year-on-year to 116.3 billion yen, with the operating profit margin on sales unchanged from the previous year's 47.1% at 47.1%.

Impact on stocks 1

Biotech & Genomic Medicine · 1 stocks